Medicine
Voraxaze 1000 units powder for injection
Voraxaze 1000 units powder for injection is a prescription medicine containing Glucarpidase for intravenous use, marketed by BTG International, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store VORAXAZE refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze.
Key facts
- Active ingredient (INN)
- Glucarpidase
- Brand
- Voraxaze
- Strength
- 1000 units
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- BTG International
- Manufacturer
- BTG International
- Origin register
- US FDA, United States
- Storage
- Store VORAXAZE refrigerated at 36°F to 46°F (2°C to 8°C). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AF09 Glucarpidase
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2012
- Identifiers
- RxCUI 1242131, 1242136DailyMed set ID acaef5a6-b740-40e3-8ffe-74a75c74745cNDC 50633-210Application BLA125327
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 50633-210-11 | BTG International | 1 April 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Glucarpidase is a carboxypeptidase indicated to reduce toxic plasma methotrexate concentration (greater than 1 micromole per liter) in adult, among other approved uses. It is available as powder for injection for intravenous use. MedsAcross supplies Glucarpidase for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlucarpidaseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Voraxaze prescribing information (BTG International) · U.S. National Library of Medicine, DailyMed
- Voraxaze: European public assessment report (EPAR) · European Medicines Agency
Need Voraxaze 1000 units powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.